financetom
Business
financetom
/
Business
/
Nvidia Insider Sold Shares Worth $42,050,639, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nvidia Insider Sold Shares Worth $42,050,639, According to a Recent SEC Filing
Oct 8, 2025 12:53 AM

03:17 AM EDT, 10/08/2025 (MT Newswires) -- Jen Hsun Huang, Director, President and Chief Executive Officer, on October 03, 2025, sold 225,000 shares in Nvidia ( NVDA ) for $42,050,639. Following the Form 4 filing with the SEC, Huang has control over a total of 853,033,603 common shares of the company, with 70,783,203 shares held directly and 782,250,400 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1045810/000119764925000044/xslF345X05/wk-form4_1759876116.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Dominance of Amazon and Microsoft in cloud harming competition, UK says
Dominance of Amazon and Microsoft in cloud harming competition, UK says
Jul 31, 2025
LONDON (Reuters) -Amazon and Microsoft's dominant position in cloud computing is having an adverse effect on competition, exacerbated by technical and commercial barriers to switching, an inquiry group from Britain's antitrust regulator said. The Competition and Markets Authority (CMA) inquiry group said on Thursday the regulator should investigate whether to consider designating the two companies with strategic market status (SMS)...
Biogen raises annual profit estimates on strong demand for rare disease drugs
Biogen raises annual profit estimates on strong demand for rare disease drugs
Jul 31, 2025
July 31 (Reuters) - Biogen raised its annual profit forecast on Thursday, betting on strong demand for its rare disease drugs such as Skyclarys to offset declining sales of its older multiple sclerosis drugs. On an adjusted basis, Biogen expects 2025 adjusted per-share profit between $15.50 and $16.00, compared with its previous forecast of between $14.50 and $15.50. ...
Medtech firm Integra's Q2 revenue beats expectations
Medtech firm Integra's Q2 revenue beats expectations
Jul 31, 2025
Overview * Integra Q2 revenue of $415.6 mln beats analyst expectations, per LSEG data * Adjusted EPS for Q2 at $0.45, exceeding analyst estimates, per LSEG data * GAAP net loss driven by $511 mln goodwill impairment charge Outlook * Company expects Q3 revenue between $410 mln and $420 mln * Integra Lifesciences ( IART ) sees Q3 adjusted EPS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved